Authors: CIFKOVA R PELESKA J HRADEC J ROSOLOVA H PINTEROVA E ZEMAN K ODDOUSTOCK P THIRLWELL J BOTTERI F

Citation: R. Cifkova et al., VALSARTAN AND ATENOLOL IN PATIENTS WITH SEVERE ESSENTIAL-HYPERTENSION, Journal of human hypertension, 12(8), 1998, pp. 563-567

Authors: BREMNER AD BAUR M ODDOUSTOCK P BODIN F

Citation: Ad. Bremner et al., VALSARTAN - LONG-TERM EFFICACY AND TOLERABILITY COMPARED TO LISINOPRIL IN ELDERLY PATIENTS WITH ESSENTIAL-HYPERTENSION, Clinical and experimental hypertension, 19(8), 1997, pp. 1263-1285

Authors: RUILOPE LM ALDIGIER JC PONTICELLI C ODDOUSTOCK P BOTTERI F MANN JF

Citation: Lm. Ruilope et al., SAFETY OF THE COMBINATION OF VALSARTAN (V) AND BENAZEPRIL (BZ) IN PATIENTS WITH CHRONIC RENAL-DISEASE (CRD), Journal of the American Society of Nephrology, 8, 1997, pp. 361-361

Authors: FAULHABER HD MANN JFE STEIN G JANSA U ODDOUSTOCK P SPORMANN D HEATH R KLINGL KG BODIN F

Citation: Hd. Faulhaber et al., TOLERABILITY OF VALSARTAN AND EFFECTS ON RENAL-FUNCTION IN TREATED HYPERTENSIVE PATIENTS WITH STABLE RENAL INSUFFIENCY, Journal of the American Society of Nephrology, 8, 1997, pp. 1450-1450

Authors: ARZILLI F FAVILLA S MOTOLESE M PERUZZI E ODDOUSTOCK P SALVETTI A

Citation: F. Arzilli et al., VALSARTAN, A NEW ANGIOTENSIN-II ANTAGONIST - TOLERABILITY AND EFFECTSON RENAL-FUNCTION IN PATIENTS WITH RENOVASCULAR ARTERIAL-HYPERTENSION, Journal of the American Society of Nephrology, 8, 1997, pp. 1582-1582

Authors: HOLWERDA NJ FOGARI R ANGELI P PORCELLATI C HERENG C ODDOUSTOCK P HEATH R BODIN F

Citation: Nj. Holwerda et al., VALSARTAN, A NEW ANGIOTENSIN-II ANTAGONIST FOR THE TREATMENT OF ESSENTIAL-HYPERTENSION - EFFICACY AND SAFETY COMPARED WITH PLACEBO AND ENALAPRIL, Journal of hypertension, 14(9), 1996, pp. 1147-1151